Back to FATE
CITADEL ADVISORS LLC FATE Position History
Fate Therapeutics, Inc. • Healthcare
Quarters held
54
Latest value
$28K
Q2 2026
Peak value
$23M
First seen
Q1 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2023 | $123K |
| Q1 2023 | $147K |
| Q1 2023 | $6.3M |
| Q1 2023 | $3.1M |
| Q2 2023 | $42K |
| Q2 2023 | $107K |
| Q2 2023 | $8M |
| Q2 2023 | $2.9M |
| Q3 2023 | $2K |
| Q3 2023 | $19K |
| Q3 2023 | $4.1M |
| Q3 2023 | $177K |
| Q4 2023 | $6K |
| Q4 2023 | $40K |
| Q4 2023 | $9.9M |
| Q4 2023 | $38K |
| Q1 2024 | $99K |
| Q1 2024 | $70K |
| Q1 2024 | $23M |
| Q2 2024 | $10K |
| Q2 2024 | $46K |
| Q2 2024 | $13.9M |
| Q2 2024 | $852K |
| Q3 2024 | $13K |
| Q3 2024 | $32K |
| Q3 2024 | $15M |
| Q4 2024 | $26K |
| Q4 2024 | $26K |
| Q4 2024 | $7.1M |
| Q4 2024 | $154K |
| Q1 2025 | $21K |
| Q1 2025 | $4K |
| Q1 2025 | $3.4M |
| Q2 2025 | $4.8M |
| Q2 2025 | $68K |
| Q2 2025 | $285K |
| Q2 2025 | $15K |
| Q3 2025 | $837K |
| Q3 2025 | $42K |
| Q3 2025 | $201K |
| Q3 2025 | $22K |
| Q4 2025 | $736K |
| Q4 2025 | $33K |
| Q1 2026 | $1.1M |
| Q1 2026 | $81K |
| Q1 2026 | $33K |
| Q2 2026 | $1.8M |
| Q2 2026 | $243K |
| Q2 2026 | $887K |
| Q2 2026 | $28K |
| Q2 2026 | $1.8M |
| Q2 2026 | $243K |
| Q2 2026 | $887K |
| Q2 2026 | $28K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $28K | 10.4K | — | — |
| Q2 2026 | $887K | 328.7K | — | — |
| Q2 2026 | $243K | 89.9K | — | — |
| Q2 2026 | $1.8M | 664.6K | — | — |
| Q2 2026 | $28K | 10.4K | — | — |
| Q2 2026 | $887K | 328.7K | — | — |
| Q2 2026 | $243K | 89.9K | — | — |
| Q2 2026 | $1.8M | 664.6K | — | — |
| Q1 2026 | $33K | 27.3K | — | — |
| Q1 2026 | $81K | 67.5K | — | — |
| Q1 2026 | $1.1M | 875.4K | — | — |
| Q4 2025 | $33K | 33.2K | — | — |
| Q4 2025 | $736K | 749.3K | — | — |
| Q3 2025 | $22K | 17.5K | — | — |
| Q3 2025 | $201K | 159.9K | — | — |
| Q3 2025 | $42K | 33.6K | — | — |
| Q3 2025 | $837K | 664.6K | — | — |
| Q2 2025 | $15K | 13.4K | — | — |
| Q2 2025 | $285K | 254.7K | — | — |
| Q2 2025 | $68K | 61.1K | — | — |
| Q2 2025 | $4.8M | 4.29M | — | — |
| Q1 2025 | $3.4M | 4.29M | — | — |
| Q1 2025 | $4K | 5.4K | — | — |
| Q1 2025 | $21K | 26.7K | — | — |
| Q4 2024 | $154K | 93.1K | — | — |
| Q4 2024 | $7.1M | 4.29M | — | — |
| Q4 2024 | $26K | 15.9K | — | — |
| Q4 2024 | $26K | 15.8K | — | — |
| Q3 2024 | $15M | 4.28M | — | — |
| Q3 2024 | $32K | 9.0K | — | — |
| Q3 2024 | $13K | 3.7K | — | — |
| Q2 2024 | $852K | 259.7K | — | — |
| Q2 2024 | $13.9M | 4.23M | — | — |
| Q2 2024 | $46K | 14.0K | — | — |
| Q2 2024 | $10K | 3.1K | — | — |
| Q1 2024 | $23M | 3.13M | — | — |
| Q1 2024 | $70K | 9.6K | — | — |
| Q1 2024 | $99K | 13.5K | — | — |
| Q4 2023 | $38K | 10.1K | — | — |
| Q4 2023 | $9.9M | 2.66M | — | — |
| Q4 2023 | $40K | 10.8K | — | — |
| Q4 2023 | $6K | 1.5K | — | — |
| Q3 2023 | $177K | 83.5K | — | — |
| Q3 2023 | $4.1M | 1.94M | — | — |
| Q3 2023 | $19K | 8.8K | — | — |
| Q3 2023 | $2K | 900 | — | — |
| Q2 2023 | $2.9M | 599.2K | — | — |
| Q2 2023 | $8M | 1.68M | — | — |
| Q2 2023 | $107K | 22.4K | — | — |
| Q2 2023 | $42K | 8.9K | — | — |
| Q1 2023 | $3.1M | 548.7K | — | — |
| Q1 2023 | $6.3M | 1.11M | — | — |
| Q1 2023 | $147K | 25.8K | — | — |
| Q1 2023 | $123K | 21.5K | — | — |
Other funds holding FATE
$39.7M
$31.3M
$22.5M
$18.5M
$18.4M